z-logo
open-access-imgOpen Access
Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis
Author(s) -
Omar Saeed,
Fumiyuki Otsuka,
Rohini Polavarapu,
Vinit Karmali,
Daiana Weiss,
Talina Davis,
Brad Rostad,
Kimberly Pachura,
Lila Adams,
J. Elliott,
W. Robert Taylor,
Jagat Narula,
Frank D. Kolodgie,
Renu Virmani,
Charles C. Hong,
Aloke V. Finn
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.240101
Subject(s) - foam cell , efflux , macrophage , hepcidin , inflammation , cholesterol , chemistry , microbiology and biotechnology , abca1 , endocrinology , medicine , immunology , biology , biochemistry , in vitro , transporter , gene
We recently reported that lowering of macrophage free intracellular iron increases expression of cholesterol efflux transporters ABCA1 and ABCG1 by reducing generation of reactive oxygen species. In this study, we explored whether reducing macrophage intracellular iron levels via pharmacological suppression of hepcidin can increase macrophage-specific expression of cholesterol efflux transporters and reduce atherosclerosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom